Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Speech Treatment for Minimally Verbal Children With ASD and CAS

NCT05066178 is registered in ClinicalTrials.gov with MGH Institute of Health Professions as lead sponsor.

NCT NCT05066178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05066178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Speech Treatment for Minimally Verbal Children With ASD and CAS
Lead sponsor
MGH Institute of Health Professions
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2024
Completion date
November 30, 2030
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, developmental verbal dyspraxia